Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Studying how risk factors affect outcomes in heart failure patients

Observes how lifestyle, blood markers and other conditions affect heart failure in adults.

Plain-language title generated from the registry record
Registry title: Risk Evaluation and Management in Heart Failure

Key facts

Where
Shanghai, ChinaSee the site

Where in China

  • Ruijin Hospital Shanghai Jiaotong University School of MedicineShanghai, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Ruijin Hospital
Trial code
NCT02998788
Record updated
20 December 2016
Original description
This is an prospective study conducted in a Chinese heart failure population. The study investigates the effects of cardiovascular disease risk factors such as lifestyle behaviors,biomarkers and intermediate diseases on heart failure prognosis.Read full original descriptionShow less

Risk Evaluation and Management in Heart Failure

This is an prospective study conducted in a Chinese heart failure population. The study investigates the effects of cardiovascular disease risk factors such as lifestyle behaviors,biomarkers and intermediate diseases on heart failure prognosis.

Inclusion: aged 18 and above; inpatient with one of the following clinical situations:; congestive heart failure (pulmonary edema,pulmonary congestion or peripheral edema); cardiogenic shock; Insufficient high output cardiac; with impaired cardiac function diagnosed by echocardiography; able to provide informed consent.

Exclusion: expressed refusal to participate in the baseline investigation or follow-up visits Severe co-morbidity associated with a reduction in life expectancy of less than 12 months.

ClinicalTrials.gov NCT02998788